Evaluation of Cholangiocarcinomas (CCA) by Next Generation Sequencing (NGS) Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Al-Rohil, R; Rand, JV; Jones, DM; Lee, HJ; Sheehan, CE; Otto, G; Palmer, G; Yelensky, R; Lipson, D; White, E; Balasubramanian, S; Garcia, L; Mahoney, K; Richards, T; Terzic, S; Banning, V; Curran, J; Downing, S; Miller, V; Stephens, P; Ross, JS

Published Date

  • February 1, 2013

Published In

Volume / Issue

  • 93 /

Start / End Page

  • 397A - 397A

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0023-6837

Conference Name

  • 102nd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP)

Conference Location

  • Baltimore, MD

Conference Start Date

  • March 2, 2013

Conference End Date

  • March 8, 2013